- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04811599
Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases Depending on Tongue Images
March 20, 2021 updated by: Xiuli Zuo, Shandong University
The purpose of this study is to analysize the relationship between the characteristics of tongue image and the diagnosis of gastrointestinal diseases , then develop and validate a deep learning algorithm for the diagnosis of gastrointestinal diseases depending on tongue images, so as to improve the objectiveness and intelligence of tongue diagnosis.
At the same time, gastrointestinal flora of common tongue images were analyzed in order to provide a microecological basis for understanding the relationship between tongue images and digestive tract diseases.
Study Overview
Status
Unknown
Conditions
Detailed Description
Tongue diagnosis is an important part of traditional Chinese medicine.According to traditional Chinese medicine theory,health condition can assessed by observing tougue features,including color, gloss, shape and coating of the tongue, tongue features reflect gastric mucosal state, disease classification and prognosis.
Recently, deep learning based on central neural networks (CNN) has shownTongue diagnosis is an important part of traditional Chinese medicine.According to traditional Chinese medicine theory,health condition can assessed by observing tougue features,including color, gloss, shape and coating of the tongue, tongue features reflect gastric mucosal state, disease classification and prognosis.
Recently, deep learning based on central neural networks (CNN) has shown multiple potential in detecting and diagnosing gastrointestinal diseases.
However, there is still a blank in recognition of gastrointestinal diseases .This study aims to develop and validate a deep learning algorithm for the diagnosis of digestive tract diseases depending on tongue images,and analyze gastrointestinal flora of common tongue images.
Study Type
Observational
Enrollment (Anticipated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Qilu Hospital, Shandong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients aged 18 - 80 years undergoing endoscopic examination
Description
Inclusion Criteria:
- Patients aged 18 - 80 years undergoing endoscopic examination;patients gave informed consent and signed informed consent.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
deep learning algorithm group
Before patients going through colonoscopy or gastroscopy ,taking them tongue images and collecting basic information by mobile phone with Anymed.After examination,endoscopic report and histology analysis is collected .Categorizing the images by gastrointestinal diseases,developing and validating a deep learning algorithm for the diagnosis of digestive tract diseases depending on tongue images.Extracting tougue coating,gastric mucosa and stool DNA by high-throughput sequencing,and analyzing their composation,adundance and diversity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The diagnostic accuracy of gastrointestinal diseases with deep learning algorithm
Time Frame: 1 month
|
The diagnostic accuracy of gastrointestinal diseases with deep learning algorithm.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The diagnostic sensitivity of gastrointestinal diseases with deep learning algorithm
Time Frame: 1 month
|
The diagnostic sensitivity of gastrointestinal diseases with deep learning algorithm.
|
1 month
|
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm
Time Frame: 1 month
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm
|
1 month
|
|
The diagnostic positive predictive value of gastrointestinal diseases with deep learning algorithm
Time Frame: 1 month
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm
|
1 month
|
|
The diagnostic negative predictive value of gastrointestinal diseases with deep learning algorithm
Time Frame: 1 month
|
The diagnostic specificity of gastrointestinal diseases with deep learning algorithm
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Xiuli Zuo, MD,PhD, Study Principal Investigator
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 21, 2021
Primary Completion (Anticipated)
June 1, 2022
Study Completion (Anticipated)
June 1, 2022
Study Registration Dates
First Submitted
March 20, 2021
First Submitted That Met QC Criteria
March 20, 2021
First Posted (Actual)
March 23, 2021
Study Record Updates
Last Update Posted (Actual)
March 23, 2021
Last Update Submitted That Met QC Criteria
March 20, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-SDU-QILU-G056
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Disease
-
Ethicon Endo-SurgeryCompleted
-
Massachusetts General HospitalEnrolling by invitationGastrointestinal Dysfunction | Gastrointestinal DiseaseUnited States
-
Jiangxi University of Traditional Chinese MedicineThe First Affiliated Hospital of Nanchang University; Second Affiliated Hospital... and other collaboratorsCompletedGastrointestinal DiseaseChina
-
Pharmbio Korea Co., Ltd.Not yet recruitingColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Pharmbio Korea Co., Ltd.CompletedColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Pharmbio Korea Co., Ltd.RecruitingColonic Diseases | Digestive System Disease | Gastrointestinal Disease | Intestinal DiseaseKorea, Republic of
-
Massachusetts General HospitalBill and Melinda Gates FoundationActive, not recruitingGastrointestinal DiseaseUnited States
-
Methodist Health SystemEnrolling by invitation
-
Changhai HospitalCompletedGastrointestinal DiseaseChina
-
Shandong UniversityUnknown